{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:23:50Z","timestamp":1789705430022,"version":"4.0.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dementia Platforms UK"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation program","doi-asserted-by":"publisher","award":["RG\/F\/22\/110052"],"award-info":[{"award-number":["RG\/F\/22\/110052"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"Cambridge University Hospitals NIHR Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017506","name":"Alzheimer\u2019s Society","doi-asserted-by":"publisher","award":["AS-RF-21-017"],"award-info":[{"award-number":["AS-RF-21-017"]}],"id":[{"id":"10.13039\/501100017506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral small vessel disease (cSVD) causes lacunar stroke (LS) and intracerebral haemorrhage and is the most common pathology underlying vascular dementia. However, there are few trials examining whether treatment of conventional cardiovascular risk factors reduces stroke risk in cSVD, as opposed to stroke as a whole. We used Mendelian randomization techniques to investigate which risk factors are causally related to cSVD and to evaluate whether specific drugs might be beneficial in cSVD prevention.<\/jats:p>\n                  <jats:p>We identified genetic proxies for blood pressure traits, lipids, glycaemic markers, anthropometry measures, smoking, alcohol consumption and physical activity from large-scale genome-wide association studies of European ancestry. We also selected genetic variants as proxies for drug target perturbation in hypertension, dyslipidaemia, hyperglycaemia and obesity. Mendelian randomization was performed to assess their associations with LS from the GIGASTROKE Consortium (n = 6811) and in a sensitivity analysis in a cohort of patients with MRI-confirmed LS (n = 3306). We also investigated associations with three neuroimaging features of cSVD, namely, white matter hyperintensities (n = 55 291), fractional anisotropy (n = 36 460) and mean diffusivity (n = 36 012).<\/jats:p>\n                  <jats:p>Genetic predisposition to higher systolic and diastolic blood pressure was associated with LS and cSVD imaging markers. Genetically predicted liability to diabetes, obesity, smoking, higher triglyceride levels and the ratio of triglycerides to high-density lipoprotein also showed detrimental associations with LS risk, whereas genetic predisposition to higher high-density lipoprotein concentrations and moderate-to-vigorous physical activity showed protective associations. Genetically proxied blood pressure lowering through calcium channel blockers was associated with cSVD imaging markers, whereas genetically proxied high-density lipoprotein raising through cholesteryl ester transfer protein inhibitors, triglyceride lowering through lipoprotein lipase and weight lowering through gastric inhibitory polypeptide receptor were associated with lower risk of LS.<\/jats:p>\n                  <jats:p>Our findings highlight the importance of some conventional cardiovascular risk factors, including blood pressure and body mass index, in cSVD, but not others, e.g. low-density lipoprotein. The findings also demonstrate the potential beneficial effects of calcium channel blockers on cSVD imaging markers and cholesteryl ester transfer protein inhibitors, lipoprotein lipase enhancement and gastric inhibitory polypeptide receptor obesity-targeted drugs on LS. They provide useful information for initiating future clinical trials examining secondary prevention strategies in cSVD.<\/jats:p>","DOI":"10.1093\/brain\/awae399","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T07:45:28Z","timestamp":1733816728000},"page":"1936-1949","source":"Crossref","is-referenced-by-count":12,"title":["Optimizing treatment of cardiovascular risk factors in cerebral small vessel disease using genetics"],"prefix":"10.1093","volume":"148","author":[{"given":"Fatemeh","family":"Koohi","sequence":"first","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-0928","authenticated-orcid":false,"given":"Eric L","family":"Harshfield","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London , London W12 0BZ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ge","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5365-8760","authenticated-orcid":false,"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[{"name":"MRC Biostatistics Unit, University of Cambridge , Cambridge CB2 0SR ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S","family":"Markus","sequence":"additional","affiliation":[{"name":"Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"2025060300222552500_awae399-B1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/17474930221144911","article-title":"Cerebral small vessel disease: Recent advances and future directions","volume":"18","author":"Markus","year":"2023","journal-title":"Int J Stroke"},{"key":"2025060300222552500_awae399-B2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/17474930221137019","article-title":"The global burden of cerebral small vessel disease in low-and middle-income countries: A systematic review and meta-analysis","volume":"18","author":"Lam","year":"2023","journal-title":"Int J Stroke."},{"key":"2025060300222552500_awae399-B3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/STROKEAHA.119.024150","article-title":"New treatment approaches to modify the course of cerebral small vessel diseases","volume":"51","author":"Smith","year":"2020","journal-title":"Stroke"},{"key":"2025060300222552500_awae399-B4","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/STROKEAHA.111.613752","article-title":"Oxfordshire community stroke project classification poorly differentiates small cortical and subcortical infarcts","volume":"42","author":"Asdaghi","year":"2011","journal-title":"Stroke"},{"key":"2025060300222552500_awae399-B5","first-page":"506","article-title":"Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"2025060300222552500_awae399-B6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/23969873231219416","article-title":"European Stroke Organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke","volume":"9","author":"Wardlaw","year":"2024","journal-title":"Eur Stroke J"},{"key":"2025060300222552500_awae399-B7","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"2025060300222552500_awae399-B8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12688\/wellcomeopenres.16544.1","article-title":"Mendelian randomization for studying the effects of perturbing drug targets","volume":"6","author":"Gill","year":"2021","journal-title":"Wellcome Open Res"},{"key":"2025060300222552500_awae399-B9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajhg.2022.12.017","article-title":"Using genetic association data to guide drug discovery and development: Review of methods and applications","volume":"110","author":"Burgess","year":"2023","journal-title":"Am J Hum Genet"},{"key":"2025060300222552500_awae399-B10","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"2025060300222552500_awae399-B11","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"key":"2025060300222552500_awae399-B12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature"},{"key":"2025060300222552500_awae399-B13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat Genet"},{"key":"2025060300222552500_awae399-B14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","article-title":"The trans-ancestral genomic architecture of glycemic traits","volume":"53","author":"Chen","year":"2021","journal-title":"Nat Genet"},{"key":"2025060300222552500_awae399-B15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41588-023-01625-2","article-title":"Comprehensive genetic study of the insulin resistance marker TG: HDL-C in the UK Biobank","volume":"56","author":"Oliveri","year":"2024","journal-title":"Nat Genet"},{"key":"2025060300222552500_awae399-B16","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1038\/s41467-022-35553-2","article-title":"Genomics and phenomics of body mass index reveals a complex disease network","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"key":"2025060300222552500_awae399-B17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/hmg\/ddy327","article-title":"Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry","volume":"28","author":"Pulit","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2025060300222552500_awae399-B18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use","volume":"51","author":"Liu","year":"2019","journal-title":"Nat Genet"},{"key":"2025060300222552500_awae399-B19","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1017\/S0033291719002678","article-title":"Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: A Mendelian randomisation study","volume":"50","author":"Wootton","year":"2020","journal-title":"Psychol Med"},{"key":"2025060300222552500_awae399-B20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41588-022-01165-1","article-title":"Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention","volume":"54","author":"Wang","year":"2022","journal-title":"Nat Genet"},{"key":"2025060300222552500_awae399-B21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries","volume":"611","author":"Mishra","year":"2022","journal-title":"Nature"},{"key":"2025060300222552500_awae399-B22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/STROKEAHA.123.044937","article-title":"Does thrombosis play a causal role in lacunar stroke and cerebral small vessel disease?","volume":"55","author":"Koohi","year":"2024","journal-title":"Stroke"},{"key":"2025060300222552500_awae399-B23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1474-4422(21)00031-4","article-title":"Genetic basis of lacunar stroke: A pooled analysis of individual patient data and genome-wide association studies","volume":"20","author":"Traylor","year":"2021","journal-title":"Lancet Neurol"},{"key":"2025060300222552500_awae399-B24","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025060300222552500_awae399-B25","doi-asserted-by":"crossref","unstructured":"Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience. 2015;4:s13742\u2013s13015.","DOI":"10.1186\/s13742-015-0047-8"},{"key":"2025060300222552500_awae399-B26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Gibbs","year":"2015","journal-title":"Nature"},{"key":"2025060300222552500_awae399-B27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.118.038814","article-title":"Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects","volume":"140","author":"Gill","year":"2019","journal-title":"Circulation"},{"key":"2025060300222552500_awae399-B28","doi-asserted-by":"crossref","first-page":"e002711","DOI":"10.1161\/CIRCGEN.119.002711","article-title":"Genetic determinants of lipids and cardiovascular disease outcomes: A wide-angled Mendelian randomization investigation","volume":"12","author":"Allara","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2025060300222552500_awae399-B29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00125-023-05925-4","article-title":"Genetically proxied glucose-lowering drug target perturbation and risk of cancer: A Mendelian randomisation analysis","volume":"66","author":"Yarmolinsky","year":"2023","journal-title":"Diabetologia"},{"key":"2025060300222552500_awae399-B30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJMoa1803180","article-title":"Effect of systolic and diastolic blood pressure on cardiovascular outcomes","volume":"381","author":"Flint","year":"2019","journal-title":"N Engl J Med."},{"key":"2025060300222552500_awae399-B31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr Rev"},{"key":"2025060300222552500_awae399-B32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2025060300222552500_awae399-B33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"2025060300222552500_awae399-B34","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"2025060300222552500_awae399-B35","doi-asserted-by":"crossref","first-page":"e343-e351","DOI":"10.1212\/WNL.0000000000013120","article-title":"Cardiovascular risk factors and MRI markers of cerebral small vessel disease: A Mendelian randomization study","volume":"98","author":"Taylor-Bateman","year":"2022","journal-title":"Neurology"},{"key":"2025060300222552500_awae399-B36","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1212\/WNL.0000000000009814","article-title":"Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes","volume":"95","author":"Georgakis","year":"2020","journal-title":"Neurology"},{"key":"2025060300222552500_awae399-B37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jama.2019.10551","article-title":"SPRINT MIND Investigators for the SPRINT Research Group: Association of intensive vs standard blood pressure control with cerebral white matter lesions","volume":"322","author":"Nasrallah","year":"2019","journal-title":"JAMA"},{"key":"2025060300222552500_awae399-B38","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"2025060300222552500_awae399-B39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.HYP.0000174591.42889.a2","article-title":"Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention","volume":"46","author":"Verdecchia","year":"2005","journal-title":"Hypertension"},{"key":"2025060300222552500_awae399-B40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"2025060300222552500_awae399-B41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/STROKEAHA.119.026739","article-title":"Blood pressure variability and cerebral small vessel disease: A systematic review and meta-analysis of population-based cohorts","volume":"51","author":"Ma","year":"2020","journal-title":"Stroke"},{"key":"2025060300222552500_awae399-B42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","article-title":"Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis","volume":"375","author":"Webb","year":"2010","journal-title":"The Lancet"},{"key":"2025060300222552500_awae399-B43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/awz413","article-title":"Genetic determinants of blood lipids and cerebral small vessel disease: Role of high-density lipoprotein cholesterol","volume":"143","author":"Georgakis","year":"2020","journal-title":"Brain"},{"key":"2025060300222552500_awae399-B44","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/eurheartj\/ehab889","article-title":"CETP inhibitors revisited","volume":"43","author":"Laufs","year":"2022","journal-title":"Eur Heart J"},{"key":"2025060300222552500_awae399-B45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2018.2866","article-title":"Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes","volume":"3","author":"Lotta","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025060300222552500_awae399-B46","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/eurheartj\/ehaa972","article-title":"Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: A drug-target Mendelian randomization analysis","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"key":"2025060300222552500_awae399-B47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drudis.2016.10.007","article-title":"Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases","volume":"22","author":"Geldenhuys","year":"2017","journal-title":"Drug Discov Today"},{"key":"2025060300222552500_awae399-B48","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/STROKEAHA.107.482216","article-title":"Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke","volume":"38","author":"Kunte","year":"2007","journal-title":"Stroke"},{"key":"2025060300222552500_awae399-B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-024-02255-6","article-title":"SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: A mediation Mendelian randomization study","volume":"23","author":"Lv","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2025060300222552500_awae399-B50","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/STROKEAHA.107.498535","article-title":"Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability study","volume":"39","author":"Gouw","year":"2008","journal-title":"Stroke"},{"key":"2025060300222552500_awae399-B51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1212\/WNL.0b013e318227b227","article-title":"Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline","volume":"77","author":"Debette","year":"2011","journal-title":"Neurology"},{"key":"2025060300222552500_awae399-B52","doi-asserted-by":"crossref","first-page":"20587392211070402","DOI":"10.1177\/20587392211070402","article-title":"Glucose-dependent insulinotropic polypeptide and tissue inflammation: Implications for atherogenic cardiovascular disease","volume":"20","author":"He","year":"2022","journal-title":"Eur J Inflamm"},{"key":"2025060300222552500_awae399-B53","doi-asserted-by":"crossref","first-page":"eaat3392","DOI":"10.1126\/scitranslmed.aat3392","article-title":"Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models","volume":"10","author":"Killion","year":"2018","journal-title":"Sci Transl Med"},{"key":"2025060300222552500_awae399-B54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"V\u00e9niant","year":"2024","journal-title":"Nat Metab"},{"key":"2025060300222552500_awae399-B55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/WNL.0b013e31823efc42","article-title":"Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) study","volume":"78","author":"Bezerra","year":"2012","journal-title":"Neurology"},{"key":"2025060300222552500_awae399-B56","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1161\/STROKEAHA.107.513176","article-title":"Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study","volume":"39","author":"van Dijk","year":"2008","journal-title":"Stroke"},{"key":"2025060300222552500_awae399-B57","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jnnp-2016-315324","article-title":"Prevalence, risk factors and consequences of cerebral small vessel diseases: Data from three Asian countries","volume":"88","author":"Hilal","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025060300222552500_awae399-B58","doi-asserted-by":"crossref","first-page":"148884","DOI":"10.1016\/j.brainres.2024.148884","article-title":"Exploring the neuroprotective role of physical activity in cerebral small vessel disease","volume":"1833","author":"Anderson","year":"2024","journal-title":"Brain Res"},{"key":"2025060300222552500_awae399-B59","doi-asserted-by":"crossref","first-page":"117016","DOI":"10.1016\/j.jns.2020.117016","article-title":"Cerebral small vessel disease in community-dwelling older adults living in remote rural settings","volume":"416","author":"Del Brutto","year":"2020","journal-title":"J Neurol Sci"},{"key":"2025060300222552500_awae399-B60","doi-asserted-by":"crossref","first-page":"e107413","DOI":"10.1371\/journal.pone.0107413","article-title":"Physical activity and cardiorespiratory fitness are beneficial for white matter in low-fit older adults","volume":"9","author":"Burzynska","year":"2014","journal-title":"PLoS One"},{"key":"2025060300222552500_awae399-B61","doi-asserted-by":"crossref","first-page":"e12224","DOI":"10.1002\/trc2.12224","article-title":"Aerobic exercise in older people with subclinical sporadic cerebral small vessel disease: A randomized clinical trial","volume":"7","author":"Wong","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"2025060300222552500_awae399-B62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2019.02.030","article-title":"Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer\u2019s disease: The AIBL active trial","volume":"89","author":"Venkatraman","year":"2020","journal-title":"Neurobiol Aging"},{"key":"2025060300222552500_awae399-B63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12603-017-0959-3","article-title":"Physical activity and changes in white matter hyperintensities over three years","volume":"22","author":"Moon","year":"2018","journal-title":"J Nutr Health Aging"},{"key":"2025060300222552500_awae399-B64","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1080\/13557858.2021.1913484","article-title":"Association of physical activity levels and brain white matter in older Latino adults","volume":"27","author":"Balbim","year":"2022","journal-title":"Ethn Health"},{"key":"2025060300222552500_awae399-B65","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/1747493020984090","article-title":"Relation between physical activity and cerebral small vessel disease: A nine-year prospective cohort study","volume":"16","author":"Landman","year":"2021","journal-title":"Int J Stroke"},{"key":"2025060300222552500_awae399-B66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gepi.22522","article-title":"Bias correction for inverse variance weighting Mendelian randomization","volume":"47","author":"Mounier","year":"2023","journal-title":"Genet Epidemiol"},{"key":"2025060300222552500_awae399-B67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","article-title":"Million veteran program: A mega-biobank to study genetic influences on health and disease","volume":"70","author":"Gaziano","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025060300222552500_awae399-B68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCGENETICS.108.829747","article-title":"Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts","volume":"2","author":"Psaty","year":"2009","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae399\/61052414\/awae399.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/148\/6\/1936\/61052414\/awae399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/148\/6\/1936\/61052414\/awae399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:22:45Z","timestamp":1748910165000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/148\/6\/1936\/7921487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,11]]},"published-print":{"date-parts":[[2025,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae399","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2024,12,11]]}}}